Sanofi Challenges J&J’s Darzalex With Blackstone Pact For SC Sarclisa
Could Receive €300m From Private Equity Firm
The French major has entered a risk-sharing collaboration with Blackstone focused on a new formulation of multiple myeloma drug Sarclisa, which could help it take on market leader Darzalex.
